Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Enterprise Value (2016 - 2025)

Assembly Biosciences has reported Enterprise Value over the past 11 years, most recently at -$248.1 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$248.1 million for Q4 2025, down 121.37% from a year ago — trailing twelve months through Dec 2025 was -$248.1 million (down 121.37% YoY), and the annual figure for FY2025 was -$248.1 million, down 121.37%.
  • Enterprise Value for Q4 2025 was -$248.1 million at Assembly Biosciences, down from -$232.6 million in the prior quarter.
  • Over the last five years, Enterprise Value for ASMB hit a ceiling of -$46.2 million in Q3 2023 and a floor of -$248.1 million in Q4 2025.
  • Median Enterprise Value over the past 5 years was -$112.5 million (2024), compared with a mean of -$128.3 million.
  • Biggest five-year swings in Enterprise Value: skyrocketed 57.47% in 2023 and later plummeted 144.92% in 2025.
  • Assembly Biosciences' Enterprise Value stood at -$146.6 million in 2021, then surged by 37.52% to -$91.6 million in 2022, then tumbled by 42.18% to -$130.2 million in 2023, then increased by 13.95% to -$112.1 million in 2024, then tumbled by 121.37% to -$248.1 million in 2025.
  • The last three reported values for Enterprise Value were -$248.1 million (Q4 2025), -$232.6 million (Q3 2025), and -$75.0 million (Q2 2025) per Business Quant data.